GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArriVent BioPharma Inc (NAS:AVBP) » Definitions » Pretax Margin %

AVBP (ArriVent BioPharma) Pretax Margin % : % (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is ArriVent BioPharma Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. ArriVent BioPharma's Pre-Tax Income for the three months ended in Dec. 2024 was $-20.63 Mil. ArriVent BioPharma's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, ArriVent BioPharma's pretax margin for the quarter that ended in Dec. 2024 was %.

The historical rank and industry rank for ArriVent BioPharma's Pretax Margin % or its related term are showing as below:


AVBP's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -137.34
* Ranked among companies with meaningful Pretax Margin % only.

ArriVent BioPharma Pretax Margin % Historical Data

The historical data trend for ArriVent BioPharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArriVent BioPharma Pretax Margin % Chart

ArriVent BioPharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Pretax Margin %
- - - -

ArriVent BioPharma Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ArriVent BioPharma's Pretax Margin %

For the Biotechnology subindustry, ArriVent BioPharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArriVent BioPharma's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArriVent BioPharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where ArriVent BioPharma's Pretax Margin % falls into.


;
;

ArriVent BioPharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

ArriVent BioPharma's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-80.488/0
= %

ArriVent BioPharma's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-20.633/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ArriVent BioPharma  (NAS:AVBP) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


ArriVent BioPharma Pretax Margin % Related Terms

Thank you for viewing the detailed overview of ArriVent BioPharma's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ArriVent BioPharma Business Description

Traded in Other Exchanges
N/A
Address
18 Campus Boulevard, Suite 100, Newtown Square, Philadelphia, PA, USA, 19073
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.